Quick Answer
COGNITION THERAPEUTICS INC reported Cash And Cash Equivalents At Carrying Value of $36.81 million for the year ending 2025.
- COGNITION THERAPEUTICS INC showed an increase of +47.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from COGNITION THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), COGNITION THERAPEUTICS INC's Cash And Cash Equivalents At Carrying Value has grown by 609.4%.
- Historical annual values: Fiscal year 2025: $36.81 million | Fiscal year 2024: $25.01 million | Fiscal year 2023: $29.92 million | Fiscal year 2022: $41.56 million | Fiscal year 2021: $54.72 million | Fiscal year 2020: $5.19 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: